If you fall into any of these buckets, microdosing is unlikely to solve the underlying problem: BMI over 35 with obesity-related conditions (Type 2 diabetes, hypertension, sleep apnea, PCOS) History of bariatric surgery with significant weight regain Plateaued at a microdose for more than 4 to 6 months with no meaningful progress Have tried microdosing twice or more and stopped both times Need to lose more than 50 pounds to reach a healthy weight At BodEvolve Bariatric & Cosmetic Surgery Center, dr Frenzel works with patients across Texas who came in thinking a GLP-1 microdose would be the answer, and left with a clearer plan that actually matched their goals
This website is an educational resource designed to help you understand what the blend is, how each peptide is thought to work, what benefits people typically pursue, how protocols are commonly structured (high level), and what major safety, legality, and research limitations you should know before making any decisions
Clinical trial data on tirzepatide show average losses of 15 to 20.9% of body weight over 72 weeks across dose levels in adults without diabetes
However, keeping track of your symptoms can help you and your healthcare provider determine whether your response requires further investigation
Our products are designed exclusively for in-vitro research (i.e., experiments conducted outside of a living organism, typically in glassware such as test tubes or petri dishes)